Rtw Investments as of March 31, 2023
Portfolio Holdings for Rtw Investments
Rtw Investments holds 60 positions in its portfolio as reported in the March 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Prometheus Biosciences | 7.3 | $351M | 3.3M | 107.32 | |
| Ptc Therapeutics I (PTCT) | 7.2 | $344M | 7.1M | 48.44 | |
| Alnylam Pharmaceuticals (ALNY) | 7.0 | $337M | 1.7M | 200.32 | |
| Rocket Pharmaceuticals (RCKT) | 6.3 | $303M | 18M | 17.13 | |
| Immunocore Hldgs Ads (IMCR) | 5.8 | $279M | 5.6M | 49.44 | |
| Masimo Corporation (MASI) | 5.8 | $277M | 1.5M | 184.54 | |
| Axsome Therapeutics (AXSM) | 4.9 | $233M | 3.8M | 61.68 | |
| Penumbra (PEN) | 3.9 | $188M | 673k | 278.69 | |
| Argenx Se Sponsored Adr (ARGX) | 3.7 | $180M | 482k | 372.58 | |
| Ultragenyx Pharmaceutical (RARE) | 3.6 | $171M | 4.3M | 40.10 | |
| Thermo Fisher Scientific (TMO) | 3.5 | $167M | 290k | 576.37 | |
| Establishment Labs Holdings Ord (ESTA) | 3.4 | $162M | 2.4M | 67.74 | |
| ACADIA Pharmaceuticals (ACAD) | 3.2 | $155M | 8.2M | 18.82 | |
| Natera (NTRA) | 3.0 | $145M | 2.6M | 55.52 | |
| Mirati Therapeutics | 2.8 | $136M | 3.6M | 37.18 | |
| Celldex Therapeutics Com New (CLDX) | 2.3 | $111M | 3.1M | 35.98 | |
| Protagonist Therapeutics (PTGX) | 2.2 | $106M | 4.6M | 23.00 | |
| Health Sciences Acq Corp 2 (OBIO) | 2.1 | $100M | 5.1M | 19.57 | |
| Avidity Biosciences Ord (RNA) | 2.0 | $98M | 6.4M | 15.35 | |
| Vericel (VCEL) | 2.0 | $97M | 3.3M | 29.32 | |
| Bruker Corporation (BRKR) | 1.9 | $94M | 1.2M | 78.84 | |
| Cytokinetics Com New (CYTK) | 1.9 | $91M | 2.6M | 35.19 | |
| Illumina (ILMN) | 1.8 | $88M | 376k | 232.55 | |
| Avadel Pharmaceuticals Sponsored Adr (AVDL) | 1.1 | $53M | 5.7M | 9.16 | |
| 10x Genomics Cl A Com (TXG) | 1.1 | $52M | 929k | 55.79 | |
| Axonics Modulation Technolog (AXNX) | 1.0 | $48M | 885k | 54.56 | |
| Ventyx Biosciences (VTYX) | 1.0 | $47M | 1.4M | 33.50 | |
| Cutera (CUTR) | 0.9 | $44M | 1.8M | 23.62 | |
| Stoke Therapeutics (STOK) | 0.8 | $37M | 4.4M | 8.33 | |
| Tarsus Pharmaceuticals (TARS) | 0.7 | $32M | 2.5M | 12.57 | |
| Scpharmaceuticals (SCPH) | 0.6 | $30M | 3.3M | 9.07 | |
| Adicet Bio (ACET) | 0.5 | $24M | 4.2M | 5.76 | |
| Gh Research Ordinary Shares (GHRS) | 0.4 | $17M | 2.2M | 7.99 | |
| Viking Therapeutics (VKTX) | 0.3 | $17M | 1.0M | 16.65 | |
| Fulcrum Therapeutics (FULC) | 0.3 | $16M | 5.5M | 2.85 | |
| Outset Med (OM) | 0.3 | $15M | 809k | 18.40 | |
| Olink Hldg Ab Sponsored Ads (OLK) | 0.3 | $15M | 655k | 22.53 | |
| Mineralys Therapeutics (MLYS) | 0.3 | $14M | 922k | 15.66 | |
| Pmv Pharmaceuticals (PMVP) | 0.3 | $14M | 3.0M | 4.77 | |
| Milestone Pharmaceuticals (MIST) | 0.3 | $13M | 3.3M | 3.94 | |
| Roivant Sciences SHS (ROIV) | 0.2 | $12M | 1.6M | 7.38 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 0.2 | $11M | 500k | 21.39 | |
| Guardant Health (GH) | 0.2 | $10M | 431k | 23.44 | |
| Dermtech Ord ord (DMTK) | 0.2 | $10M | 2.7M | 3.68 | |
| Apyx Medical Corporation (APYX) | 0.2 | $9.8M | 3.4M | 2.88 | |
| Urogen Pharma (URGN) | 0.2 | $7.9M | 858k | 9.24 | |
| Immunic (IMUX) | 0.1 | $6.4M | 4.3M | 1.49 | |
| Allakos (ALLK) | 0.1 | $5.9M | 1.3M | 4.45 | |
| Castle Biosciences (CSTL) | 0.1 | $5.9M | 259k | 22.72 | |
| Immatics SHS (IMTX) | 0.1 | $5.8M | 845k | 6.90 | |
| Relmada Therapeutics (RLMD) | 0.1 | $4.8M | 2.1M | 2.26 | |
| Jasper Therapeutics | 0.1 | $4.2M | 2.3M | 1.81 | |
| Exagen (XGN) | 0.1 | $3.4M | 1.4M | 2.43 | |
| Akoya Biosciences (AKYA) | 0.1 | $2.7M | 328k | 8.18 | |
| Third Harmonic Bio (THRD) | 0.0 | $2.2M | 535k | 4.12 | |
| Arya Sciences Acqu Corp Iv Cl A (ARYD) | 0.0 | $1.3M | 128k | 10.35 | |
| Miromatrix Med | 0.0 | $748k | 445k | 1.68 | |
| Ys Biopharma Ordinary Shares (YS) | 0.0 | $546k | 341k | 1.60 | |
| Sight Sciences (SGHT) | 0.0 | $361k | 41k | 8.74 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $39k | 350k | 0.11 |
